Abstract
A major comorbidity of X-linked hypophosphatemia (XLH) is fibrocartilaginous tendinous insertion site mineralization resulting in painful enthesophytes that contribute to the adult clinical picture and significantly impact physical function. Enthesophytes in Hyp mice, a murine model of XLH are the result of a hyperplastic expansion of resident alkaline phosphatase, Sox9-positive mineralizing fibrochondrocytes. Here, we hypothesized hyperplasia as a compensatory physical adaptation to aberrant mechanical stresses at the level of the entheses interface inserting into pathologically soft bone. To test this hypothesis, we examined the Achilles insertion of the triceps surae developed under normal and impaired loading conditions in Hyp and WT mice. Tensile stiffness, ultimate strength, and maximum strain were measured and compared. Biomechanical testing revealed that under normal loading conditions, despite inserting into a soft bone matrix, both the enthesophyte development (9 weeks) and progression (6–8 months) of Hyp mice were equivalent to the mechanical properties of WT mice. Unloading the insertion during development significantly reduced alkaline phosphatase, Sox9-positive fibrochondrocytes. In WT mice, this correlated with a decrease in stiffness and ultimate strength relative to the control limb, confirming the critical role of mechanical loading in the development of the enthesis. Most significantly, in response to unloading, maximum strain was increased in tensile tests only in the setting of subchondral osteomalacia of Hyp mice. These data suggest that mineralizing fibrochondrocyte expansion in XLH occurs as a compensatory adaptation to the soft bone matrix.
Similar content being viewed by others
References
Beck-Nielsen SS, Brock-Jacobsen B, Gram J, Brixen K, Jensen TK (2009) Incidence and prevalence of nutritional and hereditary rickets in southern Denmark. Eur J Endocrinol 160:491–497
Carpenter TO (1997) New perspectives on the biology and treatment of X-linked hypophosphatemic rickets. Pediatr Clin North Am 44:443–466
Endo I, Fukumoto S, Ozono K, Namba N, Inoue D, Okazaki R, Yamauchi M, Sugimoto T, Minagawa M, Michigami T, Nagai M, Matsumoto T (2015) Nationwide survey of fibroblast growth factor 23 (FGF23)-related hypophosphatemic diseases in Japan: prevalence, biochemical data and treatment. Endocr J 62:811–816
Macica CM (2017) Overview of phosphorus-wasting diseases and need for phosphorus supplements. In: Uribarri J, Calvo MS (eds) Dietary phosphorus: health, nutrition, and regulatory aspects. CRC Press, Boca Raton
Francis F, Hennig S, Korn B, Reinhardt R et al (1995) A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets The HYP consortium. Nat Genet 11:130–136
Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD (2003) Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278:37419–37426
Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429–435
Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia. J Clin Endocrinol Metab 87:4957–4960
Reid IR, Hardy DC, Murphy WA, Teitelbaum SL, Bergfeld MA, Whyte MP (1989) X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults. Medicine 68:336–352
Hughes M, Macica C, Meriano C, Doyle M (2020) Giving credence to the experience of X-linked hypophosphatemia in adulthood: an interprofessional mixed-methods study. J Patient Cent Res Rev 7:176–188
Steele A, Gonzalez R, Garbalosa JC, Steigbigel K, Grgurich T, Parisi EJ, Feinn RS, Tommasini SM, Macica CM (2020) Osteoarthritis, osteophytes, and enthesophytes affect biomechanical function in adults with X-linked hypophosphatemia. J Clin Endocrinol Metabol 105:e1798
Skrinar A, Dvorak-Ewell M, Evins A, Macica C, Linglart A, Imel EA, Theodore-Oklota C, San Martin J (2019) The lifelong impact of X-linked hypophosphatemia: results from a burden of disease survey. J Endocr Soc 3:1321–1334
Faraji-Bellee CA, Cauliez A, Salmon B, Fogel O, Zhukouskaya V, Benoit A, Schinke T, Roux C, Linglart A, Miceli-Richard C, Chaussain C, Briot K, Bardet C (2020) Development of enthesopathies and joint structural damage in a murine model of X-linked hypophosphatemia. Front Cell Dev Biol 8:854
Liang G, Katz LD, Insogna KL, Carpenter TO, Macica CM (2009) Survey of the enthesopathy of X-linked hypophosphatemia and its characterization in Hyp mice. Calcif Tissue Int 85:235–246
Karaplis AC, Bai X, Falet JP, Macica CM (2012) Mineralizing enthesopathy is a common feature of renal phosphate-wasting disorders attributed to FGF23 and is exacerbated by standard therapy in hyp mice. Endocrinology 153:5906–5917
Che H, Roux C, Etcheto A, Rothenbuhler A, Kamenicky P, Linglart A, Briot K (2016) Impaired quality of life in adults with X-linked hypophosphatemia and skeletal symptoms. Eur J Endocrinol 174:325–333
Herrou J, Picaud AS, Lassalle L, Pacot L, Chaussain C, Merzoug V, Herve A, Gadion M, Rothenbuhler A, Kamenicky P, Roux C, Linglart A, Duplan MB, Briot K (2022) Prevalence of enthesopathies in adults with X-linked hypophosphatemia: analysis of risk factors. J Clin Endocrinol Metab 107:e224–e235
Liu ES, Martins JS, Zhang W, Demay MB (2018) Molecular analysis of enthesopathy in a mouse model of hypophosphatemic rickets. Development. https://doi.org/10.1242/dev.163519
Liang G, Vanhouten J, Macica CM (2011) An atypical degenerative osteoarthropathy in Hyp mice is characterized by a loss in the mineralized zone of articular cartilage. Calcif Tissue Int 89:151–162
Dyment NA, Breidenbach AP, Schwartz AG, Russell RP, Aschbacher-Smith L, Liu H, Hagiwara Y, Jiang R, Thomopoulos S, Butler DL, Rowe DW (2015) Gdf5 progenitors give rise to fibrocartilage cells that mineralize via hedgehog signaling to form the zonal enthesis. Dev Biol 405:96–107
Thomopoulos S, Kim HM, Rothermich SY, Biederstadt C, Das R, Galatz LM (2007) Decreased muscle loading delays maturation of the tendon enthesis during postnatal development. J Orthop Res 25:1154–1163
Mikic B, Schalet BJ, Clark RT, Gaschen V, Hunziker EB (2001) GDF-5 deficiency in mice alters the ultrastructure, mechanical properties and composition of the Achilles tendon. J Orthop Res 19:365–371
Benjamin M, Kumai T, Milz S, Boszczyk BM, Boszczyk AA, Ralphs JR (2002) The skeletal attachment of tendons–tendon “entheses.” Comp Biochem Physiol 133:931–945
Benjamin M, Ralphs JR (2000) The cell and developmental biology of tendons and ligaments. Int Rev Cytol 196:85–130
Gao J, Messner K, Ralphs JR, Benjamin M (1996) An immunohistochemical study of enthesis development in the medial collateral ligament of the rat knee joint. Anat Embryol 194:399–406
Benjamin M, Toumi H, Suzuki D, Hayashi K, McGonagle D (2009) Evidence for a distinctive pattern of bone formation in enthesophytes. Ann Rheum Dis 68:1003–1010
Xu Y, Murrell GA (2008) The basic science of tendinopathy. Clin Orthop Relat Res 466:1528–1538
Liu CF, Breidenbach A, Aschbacher-Smith L, Butler D, Wylie C (2013) A role for hedgehog signaling in the differentiation of the insertion site of the patellar tendon in the mouse. PLoS ONE 8:e65411
Schwartz AG, Long F, Thomopoulos S (2015) Enthesis fibrocartilage cells originate from a population of Hedgehog-responsive cells modulated by the loading environment. Development (Cambridge, England) 142:196–206
O’Conor CJ, Case N, Guilak F (2013) Mechanical regulation of chondrogenesis. Stem Cell Res Ther 4:61
Macica CM, King HE, Wang M, McEachon CL, Skinner CW, Tommasini SM (2016) Novel anatomic adaptation of cortical bone to meet increased mineral demands of reproduction. Bone 85:59–69
Amiel D, Woo SL, Harwood FL, Akeson WH (1982) The effect of immobilization on collagen turnover in connective tissue: a biochemical-biomechanical correlation. Acta Orthop Scand 53:325–332
Bikle DD, Halloran BP (1999) The response of bone to unloading. J Bone Miner Metab 17:233–244
Hayashibara T, Hiraga T, Sugita A, Wang L, Hata K, Ooshima T, Yoneda T (2007) Regulation of osteoclast differentiation and function by phosphate: potential role of osteoclasts in the skeletal abnormalities in hypophosphatemic conditions. J Bone Miner Res 22:1743–1751
Connor J, Olear EA, Insogna KL, Katz L, Baker S, Kaur R, Simpson CA, Sterpka J, Dubrow R, Zhang JH, Carpenter TO (2015) Conventional therapy in adults with X-linked hypophosphatemia: effects on enthesopathy and dental disease. J Clin Endocrinol Metab 100:3625–3632
Carpenter TO, Imel EA, Holm IA, Jan de Beur SM, Insogna KL (2011) A clinician’s guide to X-linked hypophosphatemia. J Bone Miner Res 26:1381–1388
Glorieux FH, Bordier PJ, Marie P, Delvin EE, Travers R (1978) Inadequate bone response to phosphate and vitamin D in familial hypophosphatemic rickets (FHR). Adv Exp Med Biol 103:227–232
Imel EA, Glorieux FH, Whyte MP, Munns CF, Ward LM, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Pitukcheewanont P, Sochett E, Hogler W, Muroya K, Tanaka H, Gottesman GS, Biggin A, Perwad F, Mao M, Chen CY, Skrinar A, San Martin J, Portale AA (2019) Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial. Lancet 393:2416–2427
Insogna KL, Rauch F, Kamenicky P, Ito N, Kubota T, Nakamura A, Zhang L, Mealiffe M, San Martin J, Portale AA (2019) Burosumab improved histomorphometric measures of osteomalacia in adults with X-linked hypophosphatemia: a phase 3, single-arm, international trial. J Bone Miner Res 34:2183–2191
Cauliez A, Zhukouskaya VV, Hilliquin S, Sadoine J, Slimani L, Miceli-Richard C, Briot K, Linglart A, Chaussain C, Bardet C (2020) Impact of early conventional treatment on adult bone and joints in a murine model of X-linked hypophosphatemia. Front Cell Dev Biol 8:591417
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Carolyn M. Macica, Jack Luo and Steven M. Tommasini have no financial or conflicts of interests to disclose.
Ethical Approval
None.
Human and Animal Rights and Informed Consent
All animal procedures were approved by the Institutional Animal Care and Use Committee at Yale University and experiments conducted in accordance with the NIH Guide for the Care and Use of Laboratory Animals. No human studies were performed in the course of these experiments.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Macica, C.M., Luo, J. & Tommasini, S.M. The Enthesopathy of XLH Is a Mechanical Adaptation to Osteomalacia: Biomechanical Evidence from Hyp Mice. Calcif Tissue Int 111, 313–322 (2022). https://doi.org/10.1007/s00223-022-00989-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-022-00989-7